References
- Montagut C, Dalmases A, Bellosillo B, Crespo M, Pairet S, Iglesias M, et al. Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer. Nat Med 2012; 18:221 - 3; http://dx.doi.org/10.1038/nm.2609; PMID: 22270724
- Misale S, Yaeger R, Hobor S, Scala E, Janakiraman M, Liska D, et al. Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer. Nature 2012; •••; http://dx.doi.org/10.1038/nature11156; PMID: 22722830
- Yonesaka K, Zejnullahu K, Okamoto I, Satoh T, Cappuzzo F, Souglakos J, et al. Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximab. Sci Transl Med 2011; 3:99ra86; http://dx.doi.org/10.1126/scitranslmed.3002442; PMID: 21900593
- Jefferis R, Lefranc MP. Human immunoglobulin allotypes: possible implications for immunogenicity. MAbs 2009; 1:332 - 8; http://dx.doi.org/10.4161/mabs.1.4.9122; PMID: 20073133
- Grubb R. Advances in human immunoglobulin allotypes. Exp Clin Immunogenet 1995; 12:191 - 7; PMID: 8534505
- Fudenberg HH, Fudenberg BR. Antibody to hereditary human gamma-globulin (Gm) factor resulting from maternal-fetal incompatibility. Science 1964; 145:170 - 1; http://dx.doi.org/10.1126/science.145.3628.170; PMID: 14171557
- Morahan G, Berek C, Miller JFAP. An idiotypic determinant formed by both immunoglobulin constant and variable regions. Nature 1983; 301:720 - 2; http://dx.doi.org/10.1038/301720a0; PMID: 6186921
- Casadevall A, Pirofski L-A. A new synthesis for antibody-mediated immunity. Nat Immunol 2012; 13:21 - 8; http://dx.doi.org/10.1038/ni.2184; PMID: 22179281
- Torres M, Fernández-Fuentes N, Fiser A, Casadevall A. The immunoglobulin heavy chain constant region affects kinetic and thermodynamic parameters of antibody variable region interactions with antigen. J Biol Chem 2007; 282:13917 - 27; http://dx.doi.org/10.1074/jbc.M700661200; PMID: 17353196
- Grubb R. The Genetic Markers of Human Immunoglobulins. New York, NY, Springer-Verlag Press, 1970.
- Schanfield MS, van Loghem E. Human immunoglobulin allotypes. In: Weir DM, editor. Handbook of Experimental Immunology. Boston, MA, Blackwell Press, 94.1-94.18, 1986.
- Chung CH, Mirakhur B, Chan E, Le QT, Berlin J, Morse M, et al. Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose. N Engl J Med 2008; 358:1109 - 17; http://dx.doi.org/10.1056/NEJMoa074943; PMID: 18337601
- Daguet A, Watier H. 2nd Charles Richet et Jules Héricourt workshop: therapeutic antibodies and anaphylaxis; May 31-June 1, 2011, Tours, France. MAbs 2011; 3:417 - 21; http://dx.doi.org/10.4161/mabs.3.5.17485; PMID: 21857165
- van Loghem E, Aalberse RC, Matsumoto H. A genetic marker of human IgE heavy chains, Em(1). Vox Sang 1984; 46:195 - 206; http://dx.doi.org/10.1111/j.1423-0410.1984.tb00075.x; PMID: 6201004